These compounds may interact with:
Peroxisome proliferator-activated receptor alpha
Potentially involved in: lipid metabolism disorder; diabetes mellitus; obesity; atherosclerosis; fatty liver disease; hyperglycemia; cancer; hypertension; liver disease; hyperinsulinism; coronary artery disease; heart disease; crohn disease; dermatitis, atopic; diabetes mellitus, experimental; diabetes mellitus, non-insulin-dependent; experimental autoimmune encephalomyelitis; fatty liver; fatty liver, alcoholic; cardiomegaly
Disease data sourced from Pharos.